This site is intended for UK healthcare professionals only.

Are you a UK healthcare professional?

We are unfortunately unable to allow patients to attend DPC

If you would like more information on diabetes care, please refer to the NHS website.

Visit the NHS website?

DPC 2022



Specialists without Borders: In pursuit of Seamless Care

17 Nov 2022
Clinical Theatre

The new Integrated Care Boards have formed across England and we look in this session to review the implications of this and how key documents such as the ‘Fuller Report’ will influence how diabetes care is delivered in this new structure.


Integrated systems of working are going to be key to delivering population health-focused interventions and we will look to some case studies showing integrated care being delivered by pharmacists in diabetes.



There is good evidence for improved outcomes e.g., safety and cost efficacy and we hope to share some of this supportive evidence.  

  • To understand how the new ICB structure may affect diabetes care in the next few years
  • To think about how we deliver more integrated care
  • To look at any supporting evidence for integrated working in diabetes care
Natasha Jacques, Medicines Optimisation Lead Pharmacist - Primary Care - NHS Arden & Greater East Midlands Commissioning Support Unit
Anna Hodgkinson, Consultant Pharmacist - Diabetes - Lambeth Diabetes Team Guy's and St Thomas' NHS Foundation Trust
Helen Oneil, Senior Clinical Pharmacist Diabetes and Frailty - South Tyneside and Sunderland NHS Foundation Trust